J., Starke, D
So that's kind of, I guess maybe the three that I would
Oral Protocol (Gut Health Focus) Loading Phase (Weeks 1 to 4): BPC-157: 250 to 500 mcg per day, oral capsule or solution, taken on an empty stomach KPV: 500 to 1,000 mcg per day, oral capsule or solution, taken with or without food Maintenance Phase (Weeks 5 to 8): BPC-157: 250 mcg per day KPV: 500 mcg per day Cycle Length: 8 weeks total, followed by a 4-week break
Activation of MC1 receptors can darken skin (hence why its precursor was a tanning agent), and indeed using bremelanotide frequently can cause increased melanin production and hyperpigmentation (darkening of the skin) in some users
Ethics declarations Ethics approval and consent to participate The experimental protocol was developed according to the ethical principles enshrined in the Declaration of Helsinki (2013 amendment) and approved by the Ethics Committee at The 908th Hospital of Chinese Peoples Liberation Army Joint Logistic Support
The effects of colchicine on a Peyronie's-like condition in an animal model